Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of CBL-514 versus placebo in participants with Dercum's disease lipomas; the trial is currently ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dercum Disease

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Dercum's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING